+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Antiandrogen"

Global PCOS Treatment Market, By Surgery (Ovarian Wedge Resection, Cyst Aspiration, Laparoscopic Ovarian Drilling), By Drug (Ovulation Inducing Agents, Insulin-Sensitizing Agents, Others), By Diagnosis, By End User, By Region, Forecast & Opportunities, 2025 - Product Thumbnail Image

Global PCOS Treatment Market, By Surgery (Ovarian Wedge Resection, Cyst Aspiration, Laparoscopic Ovarian Drilling), By Drug (Ovulation Inducing Agents, Insulin-Sensitizing Agents, Others), By Diagnosis, By End User, By Region, Forecast & Opportunities, 2025

  • Report
  • January 2021
  • Global
From
Drug Overview: relugolix - Product Thumbnail Image

Drug Overview: relugolix

  • Drug Pipelines
  • January 2018
  • 16 Pages
  • Global
From
Polycystic Ovary Syndrome. Challenging Issues in the Modern Era of Individualized Medicine - Product Thumbnail Image

Polycystic Ovary Syndrome. Challenging Issues in the Modern Era of Individualized Medicine

  • Book
  • November 2021
  • 3 Results (Page 1 of 1)
Loading Indicator

The Antiandrogen market is a segment of the Endocrine and Metabolic Disorders Drugs market. Antiandrogens are drugs that block the action of androgens, hormones that are responsible for male characteristics and reproductive functions. These drugs are used to treat conditions such as prostate cancer, hirsutism, and acne. Antiandrogens are also used to treat gender dysphoria in transgender individuals. They are available in both oral and injectable forms. Common side effects of antiandrogens include hot flashes, decreased libido, and fatigue. The Antiandrogen market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include AbbVie, AstraZeneca, Bayer, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more